Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
MainPointe Pharmaceuticals
MainPointe Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tuxarin
Chlorpheniramine
,
Codeine
2015-06-22
2032
Pain
,
Fever
,
Cough
,
Myositis
,
Rheumatoid arthritis
,
Inflammation
,
Osteoarthritis
,
Muscle spasticity
,
Muscle cramp
,
Spasm
,
Rheumatic fever
,
Gout
,
Muscle rigidity
,
Atopic dermatitis
,
Sinusitis
,
Asthma
,
Rhinitis
,
Allergic conjunctivitis
,
Common cold
,
Allergic rhinitis perennial
,
Parkinson disease
,
Vomiting
,
Nausea
,
Sleep initiation and maintenance disorders
,
Vertigo
,
Urticaria
,
Motion sickness
,
Anxiety disorders
,
Headache
,
Fatigue
,
Apnea
,
Postoperative complications
,
Anaphylaxis
,
Septic shock
,
Hypotension
,
Pruritus ani
,
Open-angle glaucoma
,
Fissure in ano
,
Hemorrhoids
,
Vasomotor rhinitis
,
Supraventricular tachycardia
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use